May 9, 2019
12,066
64
9
0.61%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:32Now PlayingA generic version of the HIV prevention pill Truvada will be available in the United States by September 2020, a year earlier than expected, according to Gilead Sciences.
When taken daily, Truvada prevents HIV transmission. This approach is called HIV pre-exposure prophylaxis (PrEP).
"Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required," Douglas Brooks, Gilead's executive director for community engagement, wrote in an email shared with NBC News by the advocacy group PrEP4All.
A month's supply of generic Truvada is available in countries around the world for as little as $70, but the drug costs $1,600 to $2,000 in the United States.
Activists launched a campaign to convince Gilead to make the generic drug more widely available to combat the global HIV epidemic.
Subscribe to our YouTube channel
TICTOC ON SOCIAL:
Follow TicToc on Twitter
Like TicToc on Facebook
Follow TicToc on Instagram
Watch all of TicToc’s videos
Listen to TicToc’s podcast
Subscribe to our newsletter
TicToc by Bloomberg is global news for the life you lead. We are a 24/7 news network that covers breaking news, politics, technology, business and entertainment stories from around the globe, supported by a network of Bloomberg’s 2,700 journalists across 120 countries.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.